The decision comes after the agency became aware of two massive orders for the anti-viral medicine. Once doctor had ordered 500 packets while another had ordered 800. Both were thought to have been ordering the drug on behalf of companies.
“If large companies decide that they want Tamiflu for all their staff, it could create a shortage,” said Björn Beermann at the Medical Products Agency.
The decision will not affect individuals’ access to the drug if they have a prescription from their doctor.
Tamiflu is usually prescribed to those who have a particularly nasty dose of the flu, old people or young people who are suffering, for example, from a heart condition.